Tavokinogene telseplasmid

DB17301InvestigationalVaccines

Tavokinogene telseplasmid consists of a DNA Plasmid Vector Encoding IL-12.

Also known as
Dna plasmid containing genes coding for the human interleukin 12 (il-12) p35 and p40 subunits that are separated by an internal ribosomal entry site (ires) and under the control of a single cytomegalovirus (cmv) promoter · Dna plasmid encoding interleukin-12 ino-9012 · DNA Plasmid Vector encoding IL-12 (pUMVC3-hIL-12-NGVL331) · Pumvc3-hil · pUMVC3-hIL-12-NGVL331
Code names
12-NGVL331 · PNGVL3-HIL-12 · TAVO

Resolves to

What you can answer from here — as of April 23, 2025

9Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Tavokinogene telseplasmid, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account